Biotech

All Articles

ArsenalBio increases $325M, rotates out of previous lead resource

.Arsenal Biosciences is actually proceeding up. The tissue therapy business has added on $325 millio...

Lilly- supported weight reduction biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...

Aelis' cannabis use drug flunks period 2b, driving Indivior to rethink $100M option

.Aelis Farma's hopes of safeguarding a quick, positive selection on a $100 million choice remittance...

ProKidney stops phase 3 trial certainly not required for tissue treatment authorization

.ProKidney has actually quit among a pair of stage 3 trials for its cell treatment for renal ailment...

Vaxcyte surges on 'remarkable' 31-valent PCV win against Pfizer

.Vaxcyte introduced what professionals named "stunning" phase 1/2 information for its 31-valent pneu...

Recursion's human brain condition test presents little evidence of effectiveness

.Recursion has actually discovered with an early test of its tech-enabled method to medicine explora...

Acepodia, Pfizer click with each other for chemistry-based cell treatment

.Contact it a case of really good chemistry: Acepodia, a biotech based on Nobel Champion scientific ...

Praxis epilepsy medication lessens confiscations in period 2 hearing

.Praxis Accuracy Medicines has actually racked up one more midphase gain in epilepsy this year, alon...

Three execs surrender as Dyne messages mixed data for DMD applicant

.After escaping a scientific hold numerous years back, Dyne Therapy has exposed new period 1/2 data ...

Arrowhead fires off phase 3 records in uncommon metabolic illness before market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its own give before a prospective showdown along with Ionis,...